Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AACR 2022 | Highlights from AACR 2022

Vivek Subbiah • 11 Apr 2022
AACR 2022
General

Vivek Subbiah, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, relates an enthusiastic joy at the opportunity to attend AACR 2022 in person and to experience presentations on exciting novel fields in oncology including targeted therapies, immunotherapies and epigenetic therapies. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.

More from Vivek Subbiah

1:17
What role does germline genetic testing have in diagnosing cancer?
Vivek Subbiah • 17 Apr 2023
1:19
Phase I/II trial of EP0031, a next generation selective RET inhibitor
Vivek Subbiah • 17 Apr 2023
0:59
What does the future hold for precision medicine in oncology?
Vivek Subbiah • 17 Apr 2023
2:04
AACR GENIE: clinical implications of defining genomic alterations in ultra-rare sarcomas
Vivek Subbiah • 11 Apr 2022

Related Videos

0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
3:10
PALOMA: subcutaneous amivantamab in advanced solid tumors
Natasha Leighl • 17 Apr 2024
The content of VJOncology is intended for healthcare professionals